# A Study of BBI503 in Adult Patients With Advanced Solid Tumors

> **NCT01781455** · PHASE1 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 311 (actual)

## Conditions studied

- Cancer, Advanced Solid Tumors

## Interventions

- **DRUG:** BBI503

## Key facts

- **NCT ID:** NCT01781455
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 311 (ACTUAL)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781455, "A Study of BBI503 in Adult Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01781455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*